Founded in 1924, BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 50 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world. Our strategic areas are Innovation, Internationalization and Quality.

Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D program. The key focus area for the Group is neurosciences.

For more information, please visit: www.bial.com

For issues of safety or others related to product quality, please contact: pharmacovigilance@bial.com